Evidence map›Paper›PMID 34675559›Full record

ArticleInfection and drug resistance2021

Molecular Analysis and Antimicrobial Resistance Pattern of Tigecycline-Non-Susceptible

Niya Hu, Dongjiang Wang, Yiqing Lin, Jun Zou, Yanling Liu, Zhigang Xiong, Jian Guo, Lingbing Zeng, Junming Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Niya Hu *Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Dongjiang Wang *Department of Laboratory Medicine, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, People's Republic of China.
Yiqing LinDepartment of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Jun ZouDepartment of Orthopedics, Jiangxi Provincial Children's Hospital, Nanchang, People's Republic of China.
Yanling LiuDepartment of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Zhigang XiongDepartment of Orthopedics, Jiangxi Provincial Children's Hospital, Nanchang, People's Republic of China.
Jian GuoDepartment of Laboratory Medicine, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, People's Republic of China.
Lingbing ZengDepartment of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Junming LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.ORCID 0000-0001-7298-2654
Nanchang University · CNJiangxi Provincial Children's Hospital · CNShanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTigecycline is one of the last resorts for carbapenem-resistant

methodsThirty-four TNSKP strains were selected during the study period, all of which were analyzed using antimicrobial susceptibility testing, multilocus sequence typing (MLST), and pulsed-field gel electrophoresis (PFGE). PCR and DNA sequencing were performed for the detection of β-lactamase genes and carbapenemase genes, and the mutation analysis of

resultsAn epidemiology analysis showed that

conclusionAs the results of this study reveal, we should take effective measures to control the increase in TNSKP.

Indexed as

carbapenem-resistantKlebsiella pneumoniaetigecycline-non-susceptible

Identifiers

PMID34675559
PMCPMC8504710
OpenAlexW3202438532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.